Collins K A, Geisinger K R, Raab S S, Silverman J F
Department of Pathology, Bowman Gray School of Medicine, Winston-Salem, North Carolina, USA.
Acta Cytol. 1996 Mar-Apr;40(2):257-62. doi: 10.1159/000333748.
The utility of fine needle aspiration biopsy (FNAB) for the diagnosis of epithelial hepatic neoplasms is now widely recognized. The liver may also play host to malignant nonepithelial stromal and lymphoreticular neoplasms, both metastatic and rarely primary. The cytomorphology of these hepatic tumors in aspiration smears is much less well known. In the current study, we examined FNAB material from hepatic lymphomas, including ancillary studies.
We collected 16 cases of lymphoma involving the liver and diagnosed by FNAB. The patients included seven women and nine men, with ages ranging from 34 to 84 years. Nine patients did not have a diagnosis of lymphoma prior to FNAB. In all cases, aspiration smears were stained by both Diff-Quik and Papanicolaou stain.
Dispersed, monomorphic lymphoid cells were usually numerous, whereas benign hepatocytes were scanty. In addition to the lymphoid appearances of individual cells, helpful clues included the presence of lymphoglandular bodies and the absence of true intercellular cohesion. There were 6 large cell, 3 immunoblastic, 2 small cell, 1 small cell cleaved, 2 mixed cell and 2 unclassified lymphomas in our FNAB series. Immunocytochemical studies were performed on 9 aspirated specimens, flow cytometry on 4 and gene rearrangement on 1. All these ancillary studies supported the cytomorphologic diagnosis of lymphoma, with approximately 90% classified as of B-cell lineage. All seven subsequent histologic examinations were confirmatory.
Other entities that must be considered in the FNAB differential diagnosis of hepatic lesions are nonlymphoreticular small cell neoplasms, inflammatory processes and sinusoidal hematopoietic cells. FNAB with ancillary studies can successfully establish the diagnosis of involvement of the liver by lymphoma.
细针穿刺活检(FNAB)在诊断上皮性肝脏肿瘤中的作用现已得到广泛认可。肝脏也可能是恶性非上皮性间质和淋巴网状肿瘤的宿主,包括转移性肿瘤,原发性肿瘤则较为罕见。这些肝脏肿瘤在穿刺涂片的细胞形态学鲜为人知。在本研究中,我们检查了肝脏淋巴瘤的FNAB材料,包括辅助检查。
我们收集了16例经FNAB诊断的累及肝脏的淋巴瘤病例。患者包括7名女性和9名男性,年龄在34至84岁之间。9例患者在FNAB之前未被诊断为淋巴瘤。所有病例的穿刺涂片均用Diff-Quik和巴氏染色法染色。
通常可见大量分散的单形性淋巴细胞,而良性肝细胞较少。除了单个细胞的淋巴细胞形态外,有用的线索包括淋巴腺小体的存在和真正细胞间黏附的缺失。在我们的FNAB系列中,有6例大细胞淋巴瘤、3例免疫母细胞淋巴瘤、2例小细胞淋巴瘤、1例小细胞裂细胞淋巴瘤、2例混合细胞淋巴瘤和2例未分类淋巴瘤。对9份吸出标本进行了免疫细胞化学研究,4份进行了流式细胞术检测,1份进行了基因重排检测。所有这些辅助检查均支持淋巴瘤的细胞形态学诊断,约90%归类为B细胞系。随后的7次组织学检查均得到证实。
在FNAB鉴别诊断肝脏病变时必须考虑的其他实体包括非淋巴网状小细胞瘤、炎症过程和窦状造血细胞。FNAB结合辅助检查能够成功确诊肝脏淋巴瘤。